Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway
Authors:
- 24 February 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (8) , 2506-2514
Abstract
B and T lymphocyte attenuator (BTLA) is a coinhibitory receptor that interacts with herpesvirus entry mediator (HVEM), and this interaction regulates pathogenesis in various immunologic diseases. In graft-versus-host disease (GVHD), BTLA unexpectedly mediates positive effects on donor T-cell survival, whereas immunologic mechanisms of this function have yet to be explored. In this study, we elucidated a role of BTLA in GVHD by applying the newly established agonistic anti-BTLA monoclonal antibody that stimulates BTLA signal without antagonizing BTLA-HVEM interaction. Our results revealed that provision of BTLA signal inhibited donor antihost T-cell responses and ameliorated GVHD with a successful engraftment of donor hematopoietic cells. These effects were dependent on BTLA signal into donor T cells but neither donor non-T cells nor recipient cells. On the other hand, expression of BTLA mutant lacking an intracellular signaling domain restored impaired survival of BTLA-deficient T cells, suggesting that BTLA also serves as a ligand that delivers HVEM prosurvival signal in donor T cells. Collectively, current study elucidated dichotomous functions of BTLA in GVHD to serve as a costimulatory ligand of HVEM and to transmit inhibitory signal as a receptor.Keywords
This publication has 40 references indexed in Scilit:
- T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding MicroenvironmentThe Journal of Immunology, 2009
- Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance InductionThe Journal of Immunology, 2009
- Unconventional ligand activation of herpesvirus entry mediator signals cell survivalProceedings of the National Academy of Sciences, 2009
- Development of autoimmune hepatitis–like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuatorArthritis & Rheumatism, 2008
- A crucial role for HVEM and BTLA in preventing intestinal inflammationJournal of Experimental Medicine, 2008
- Mouse Models of Bone Marrow TransplantationTransplantation and Cellular Therapy, 2008
- Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host diseaseBlood, 2006
- Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLABiochemical and Biophysical Research Communications, 2006
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003